Company news
Talphera, Inc. news in 2025
Talphera, Inc.'s news releases, calls and decks from 2025, newest first.
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 12, 2025
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
November 5, 2025
Talphera Announces the Appointment of Joe Todisco to Board of Directors
October 21, 2025
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
September 8, 2025
CorMedix Announces Strategic Minority Investment in Talphera
September 7, 2025
Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial
August 25, 2025
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update
August 14, 2025
Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025
August 7, 2025
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025
May 7, 2025
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 31, 2025
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
March 31, 2025
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
March 26, 2025
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
January 13, 2025